Role of hemodialysis with high cut-off membranes in a patient with a non-recognized leishmaniasis

Blood Purif. 2014;38(3-4):239-41. doi: 10.1159/000368958. Epub 2014 Dec 19.

Abstract

Background: We report here a case of a woman affected by fever, weight loss, splenomegaly, and leucopenia associated with trombocytopenia, transferred to the intensive care unit with acute kidney injury and septic shock.

Methods: Patient was treated with high cut-off continuous veno-venous hemodialysis (HCO-CVVHD).

Results: During treatment, the patient experienced a stable improvement in the hemodynamic, pulmonary function and tissue perfusion parameters. After 48 h of treatment, significant reductions in SOFA score (from 12, before starting the procedure, to 6) and in serum inflammatory mediators (as IL-6, from 599-568 pg/ml) were observed. Leishmania infection was identified as responsible of the septic condition only 48 h after removing hemodialysis. Antiprotozoal therapy was begun and the patient discharged.

Conclusions: By supporting the renal function and reducing systemic inflammation, HCO-CVVHD could be a useful bridge therapy. This procedure allowed the medical team to gain sufficient time to diagnose the type of infection and begin an etiological therapy.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / etiology
  • Acute Kidney Injury / therapy*
  • Anticoagulants / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Bacteremia / diagnosis
  • Bone Marrow Examination
  • Combined Modality Therapy
  • Corynebacterium Infections / diagnosis
  • Critical Care / methods
  • Cytokines / blood
  • Delayed Diagnosis
  • Diagnostic Errors
  • False Positive Reactions
  • Female
  • Hemofiltration / instrumentation*
  • Humans
  • Leishmaniasis / blood
  • Leishmaniasis / complications*
  • Leishmaniasis / diagnosis
  • Leishmaniasis / drug therapy
  • Membranes, Artificial*
  • Middle Aged
  • Molecular Weight
  • Pancytopenia / etiology
  • Pancytopenia / pathology
  • Permeability
  • Respiration, Artificial
  • Shock, Septic / etiology
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Anticoagulants
  • Antiprotozoal Agents
  • Cytokines
  • Membranes, Artificial
  • Vasoconstrictor Agents